We are now prospectively implementing Transpara in our screening program and we are very excited to see the results from our prospective trial. Even better, we have observed that the latest version of Transpara has significantly improved the detection performance of the system, and a higher sensitivity is achieved at high specificity.
© 2023, ScreenPoint Medical BV. All rights reserved. Transpara® is a registered trademark of ScreenPoint Medical BV. Reproduction of any material contained herein in any format or media without express written permission of ScreenPoint Medical BV is prohibited. *Disclaimer: Transpara is CE marked and FDA cleared for 2D and 3D mammography. CE (0344) certified. FDA 510(k) K210404. Not all features are available in all countries. Please check with local representatives.
